Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00205413 · ClinicalTrials.gov registry record

Surveillance For New Lung Primaries

A clinical trial, sponsored by University of Wisconsin, Madison.

Terminated
Registry status
250
Enrollment target

NCT00205413: Clinical Trial study, sponsored by University of Wisconsin, Madison.

NCT00205413 is a clinical trial that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00205413 was terminated before completion, sponsored by University of Wisconsin, Madison.

TERMINATED
Registry status
250 participants
Enrollment target

Study Summary

This clinical research protocol proposes to perform low dose helical computed tomographic (CT) scanning in 250 high-risk patients (125/year for two years) in order to detect lung carcinomas when they are small and subject to effective curative therapies.

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2002-09
Est. Completion 2006-07
University of Wisconsin, Madison

1,039 total trials

Why NCT00205413 stopped before completion

NCT00205413 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00205413 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00205413 about?

NCT00205413 is a clinical study titled "Surveillance For New Lung Primaries". This clinical research protocol proposes to perform low dose helical computed tomographic (CT) scanning in 250 high-risk patients (125/year for two years) in order to detect lung carcinomas when they are small and subject to effective curative therapies.

What is the current status of trial NCT00205413?

This trial is currently terminated. The enrollment target is 250 participants. The study started on 2002-09. Estimated completion is 2006-07.

Who is sponsoring clinical trial NCT00205413?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00205413, the US trial registry maintained by the National Library of Medicine. NCT00205413 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.